24*7 Customer Support
Lowest Price
100% Delivery Guarantee​

Lenvamed 4 Capsule

16 products sold in last 4 hours
Selling fast! Over 8 people have in their cart
Brand Name: Lenvamed 4
International Trade Name: Lenvima
Active Substance: Lenvatinib
Strength: 4mg
Category: Anti-Cancer
Manufacturer: Medicamen Biotech Ltd
Pack: 10 Capsules in a Strip
Product Form: Capsule

 

23 people are viewing this right now

Description of Lenvamed 4 (Lenvatinib 4mg) capsule 

Lenvamed 4 capsules contain 4mg Lenvatinib, a medicine used to treat particular type of cancer like liver cancer, kidney cancer, differentiated thyroid cancer, and endometrial cancer. This drug acts as a tyrosine kinase inhibitor (TKIs), and tries to inhibit the certain protein which is necessary for the growth and spread of cancer cell and it also helps to reduce the size of tumor.

Indications of Lenvamed 4 (Lenvatinib 4mg) capsule 

Lenvamed 4 capsule is given for treatment for thyroid cancer which has no response to radioactive therapy. Hepatocellular carcinoma is a common liver cancer that used along with pembrolizumab. Advanced renal cell carcinoma is a kidney cancer can be used either alone or in combination with everolimus.

Mechanism of action of Lenvamed 4 (Lenvatinib 4mg) capsule 

Lenvatinib capsule is a tyrosine kinase inhibitor that produces its action by inhibiting the supply of oxygen and nutrient which is required for the growth of cancer cell.

How to consume Lenvamed 4 (Lenvatinib 4mg) capsule 

People must use Lenvatinib capsule strictly in amount the doctor decides for you. Most often, drug is taken one time every day, and you can take it with food or without having any food. You have to make sure about swallowing each capsule whole and should not break, chew or open it.

Side Effects of Lenvamed 4 (Lenvatinib 4mg) capsule

  1.  Common side effects
    • Feeling tired
    • Experiencing high blood pressure
    • Problems with diarrhea
    • Loss in weight
    • Appetite gets lower
  1. Serious side effects
    • Heart-related cases
    • Indications of liver trouble (like having yellow skin or eyes)
    • Allergic issues (rashes itchy, or swelling)
    • Blood clots
  1. Rare side effects
    • Abnormal passage between organs
    • Thyroid malfunction
    • Severe stomach pain

Safety Advice for Lenvamed 4 (Lenvatinib 4mg) capsule

People who are using Lenvtinib need proper checking for probable bad impacts, for example, heart-related symptoms including heart failure or irregular heartbeat. The doctor might ask for often checking of the liver and kidney working too.

Breastfeeding: Limited information is available regarding the use of this medicine in patients during breastfeeding. The animal research however reveals a negative impact on the unborn child and hence it is better to steer clear of using it during breastfeeding.

Pregnancy: Limited information is available regarding the use of this medicine during pregnancy. Kindly consult with your doctor for further information.

Alcohol: There must be a reduction in taking alcohol since it might give higher risk of some impacts.

Liver: Patients having liver problems should use with care.

Lungs: If some lung disease is already there, it must be talked with your doctor before you start.

Kidney: Patients having kidney problems should use with care.

Driving: Tiredness and feeling dizzy can be possible, so machines and driving must be done with care.

Interaction of Lenvamed 4 (Lenvatinib 4mg) capsule

  •  Drug-Drug Interaction :

Mirtazapine x Lenvatinib

Another drug is recommended since Mirtazapine is prone to increase the QTc interval when used together with Lenvatinib.

Apalutamide x Lenvatinib 

The use of Apalutamide and Lenvatinib ought to be cautiously done as Apalutamide is also bound to reduce the therapy effect of Lenvatinib by increasing the excretion of this drug.

Lenvatinib x Dichlorphenamide 

Dichlorphenamide is to be prescribed carefully in case of Lenvatinib because simultaneous administration of these two agents can lead to the development of hypokalemia.

Tinidazole x Lenvatinib 

Co-prescription of Tinidazole with Lenvatinib should only be considered after taking into account, as Lenvatinib has the capacity to increase the pharmacodynamic action of Tinidazole by influencing the hepatic and intestinal metabolism.

Mavorixafor x Lenvatinib 

The co-administration of Lenvatinib and Mavorixafor should be approached with caution because Mavorixafor has the potential to increase the pharmacologic action of Lenvatinib through P-glycoprotein efflux transport modification.

  • Drug-Food Interaction:

Alcohol:

Consuming alcohol while you are receiving this medicine may cause confusion, drowsiness and dizziness which may increase the risk of accidents.

  • Drug-Disease Interaction:

Hepatic impairment:

Therapy should be administered with caution because the use of this medicine may cause liver failure.

Cardiac dysfunction:

Therapy should be administered with caution because decreased ventricular function, cardiac failure and pulmonary edema have been reported so kindly discontinue the medicine if you have history of cardiac dysfuntion or who develop heart failure during treatment.

Contraindication of Lenvamed 4 (Lenvatinib 4mg) capsule 

It is contraindicated to use this medicine in patient with history of seizure.

The side effects of using this medicine arterial thromboembolic events, proteinuria, diarrhea, gastrointestinal perforation, hypocalcemia, and reversible posterior leukoenephalopathy syndrome.

Dosage of Lenvamed 4 (Lenvatinib 4mg) capsule 

Dose depends on the type of cancer. The doctor may make changes depending upon personal tolerance and how the treatment is working.

Storage of Lenvamed 4 (Lenvatinib 4mg) capsules 

Capsules of Lenvatinib need to be kept somewhere with average room temperature conditions, protecting it from too much moisture or heat. You should always have them inside packet they are in and out of reach of children.

Missed Dose of Lenvamed 4 (Lenvatinib 4mg) capsules

 If you miss one capsule, just use planned next dose on the regular schedule. Taking two capsules together to replace a missed one is not required. Do not try to increase your next dose for this.

Other General Information of Lenvamed 4 (Lenvatinib 4mg) capsules 

The use of Lenvamed 4 Capsule might create dry skin, so using proper moisturizer is recommended by the doctors. Stay hydrated by drinking water and eat with more balanced as much as you can. Attending frequent checkups with doctor is important during treatment; you should notify any strange side effects as soon as possible. If you want further instructions or details for your case, contact your doctor.

 FAQs of Lenvamed 4 (Lenvatinib 4mg) capsule

  1. What can be done in case one feels significantly tired or slightly dizzy?

Patients who have a severe level of fatigue or vertigo must inform their doctor immediately, and the specialist will subsequently alter the dosage.

  1. Can Lenvatinib be administered together with other drugs?

All concomitant medications should be reported to the prescribing doctor to enable the prescribing physician to know about the possibilities of drug-drug interactions and avert the issues.

  1. What should be the duration of Lenvatinib?

Patients are expected to take Lenvatinib as per their dose and period as given by their clinician. Acute withdrawal can trigger harmful consequences.

  1. Am I able to administer other pharmaceutical with Lenvatinib?

When patients visit their physician, they should provide the full history of their medication since some agents will increase the likelihood of adverse events when used together with Lenvatinib.

  1. Is Lenvatinib pregnancy-decreasing?

Lenvatinib can decrease fertility in both male and female patients, thus when a patient wants to have a baby, the issue of fertility should be discussed with a physician.

Fact Box of Lenvamed 4 (Lenvatinib 4mg) Capsule:

Field Details
Generic/Molecule Name Lenvatinib
Therapeutic Class Anti-neoplastic agent
Pharmacological Class Tyrosine kinase inhibitor
Dosage form Capsule
Habit forming No
Indication Thyroid, liver, and renal cancers.

References

PubChem.: https://pubchem.ncbi.nlm.nih.gov/compound/Lenvatinib

European Medicines Agency (EMA). https://www.ema.europa.eu/en/documents/product-information/lenvima-epar-product-information_en.pdf

MedlinePlus (U.S. National Library of Medicine).
https://medlineplus.gov/druginfo/meds/a614049.html

DrugBank Online. https://go.drugbank.com/drugs/DB09078

U.S. Food and Drug Administration (FDA). https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206947s026lbl.pdf

Reviews

There are no reviews yet.

Be the first to review “Lenvamed 4 Capsule”

Your email address will not be published. Required fields are marked *